Role of Serum Lipid and Apolipoprotein Ratios in Prediction of Diabetic Retinopathy
DOI:
https://doi.org/10.46568/bios.v4i1.85Keywords:
Diabetic Retinopathy, Lipid ratios, ApolipoproteinsAbstract
Aims: The objective of the study was to determine clinical utility of different ratios of serum lipid and apolipoprotein as predictive markers for diabetic retinopathy (DR). Methodology: In this case control study, study participants were divided in to four groups, normal controls, diabetic controls, non-proliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR). Staging was done based on fundoscopy by an ophthalmologist. A fasting venous blood was assayed for Lipid profile, levels of ApoA1 and ApoB and different combination of ratios for these tests were used to assess association with DR. Results: Independently, only ApoB levels proved to be predictive of DR, but being non-specific to DR it cannot be used as independent marker. Amongst various ratios, only ratios of apolipoproteins were significantly associated with DR. Conclusion: ApoB/ApoA1 ratio is the most suited ratio for screening of DR.
References
Herman WH. The Global Burden of Diabetes: An Overview. Diabetes Mellitus in Developing Countries and Underserved Communities: Springer; 2017. p. 1-5.
Organization WH. Global report on diabetes: World Health Organization; 2016.
Dowler J. BMJ Best Practice: BMJ; 2017 [Available from: http: //bestpractice.bmj.com/topics/en-gb/532.
Wang FH, Liang YB, Zhang F, Wang JJ, Wei WB, Tao QS, et al. Prevalence of diabetic retinopathy in rural China: the Handan Eye Study. Ophthalmology 2009; 116(3): 461-7.
Xie X, Xu L, Jonas J, Wang Y. Prevalence of diabetic retinopathy among subjects with known diabetes in China: the Beijing Eye Study. European journal of ophthalmology 2009; 19(1): 91.
Mendoza-Herrera K, Quezada AD, Pedroza-Tobías A, Hernández-Alcaraz C, Fromow-Guerra J, Barquera S. Peer reviewed: A diabetic retinopathy screening tool for low-income adults in mexico. Preventing chronic disease 2017; 14.
Maffi P, Secchi A. The burden of diabetes: Emerging data. Management of Diabetic Retinopathy. 60: Karger Publishers 2017. p. 1-5.
Sasongko MB, Widyaputri F, Agni AN, Wardhana FS, Kotha S, Gupta P, et al. Prevalence of diabetic retinopathy and blindness in Indonesian adults with type 2 diabetes. Am J Ophthalmol 2017; 181: 79-87.
Sohail M. Prevalence of diabetic retinopathy among type–2 diabetes patients in Pakistan–vision registry. Pak J Ophthalmol 2014; 30(4): 204-12.
Saddiq MAA, Rehman MU, Fatima M, Hussain A, Khan AA, Mahju T, et al. Diabetic retinopathy in patients presenting to the screening clinic of a tertiary care hospital in Pakistan. Ophthalmol Pakistan 2017; 5(04): 7-9.
Muhammad Akhtar M, Hussain M. To compare the frequency & prevalence of diabetic retinopathy in type: 1 & Type: 2 at Al-shifa eye hospital, Rawalpindi. Ophthalmology 2017; 15(4): 341.
Shaikh S, Ursani TJ, Dhiloo KH, Samuel R, Talpur R, Jawed M, et al. Prevalence of diabetic retinopathy and related factors in patients with type 2 diabetes mellitus in Hyderabad and adjoining areas 2017.
Lodhi A, Panhwar F, Anwar K, Saleem R, Irfan R, Qureshi A. Diabetic Retinopathy prevalence in Urban Sindh. Sindh University Research Journal-SURJ (Science Series) 2017; 49(1).
Farasat T, Sharif S, Manzoor F, Zafar M, Naz S. Prevalence of retinopathy detected by fundoscopy among newly diagnosed type 2 diabetic patients visiting a local hospital in Lahore. Pakistan J Zool 2017; 49(1).
Zafar J, Nadeem D, Khan SA, Jawad Abbasi M, Aziz F, Saeed S. Prevalence of diabetes and its correlates in urban population of Pakistan: A Cross-sectional survey. J Pak Med Assoc 2016; 66: 922-7.
Khan AJ. Prevalence of diabetic retinopathy in Pakistani subjects. A pilot study. J Pak Med Assoc. 1991; 41(3): 49-50.
Ishaq H, Ali M, Kazmi N, Naqvi BS, Shaikh D. Prevalence of diabetic retinopathy in type II diabetic patients in a health facility in Karachi, Pakistan. Tropical J Pharm Res 2016; 15(5): 1069-76.
Butt N, Bano F, Ghani M, Ahmed AM, Majeed N. Association of serum advanced glycation (AGEs) end products, apolipoprotein-B and zinc in severity of T2DM retinopathy. Pak J Pharm Sci 2021; 34(2): 803-8.
Prajapati S, Kujur R, Tiwari U, Ranjan K. Serum lipid levels in diabetes mellitus patients with and without diabetic retinopathy: A prospective study. Int J Curr Res Med Sci 2017; 3(8): 78-88.
Du M, Martin A, Hays F, Johnson J, Farjo RA, Farjo KM. Serum retinol-binding protein-induced endothelial inflammation is mediated through the activation of toll-like receptor 4. Molecular vision 2017; 23: 185.
Zhang XZ, Tu WJ, Wang H, Zhao Q, Liu Q, Sun L, et al. Circulating serum fatty acid binding protein 4 levels predict the development of the diabetic retinopathy in type 2 diabetic patients. Am J Ophthalmol 2018.
Mukherjee B, Shankar S, Ahmed R, Singh K, Bhatia K. Association of glycated haemoglobin and serum apolipoproteins with diabetic retinopathy: An Indian overview. J Clin Diagnos Res 2017; 11(9): BC19.
Mahfouz MH, Assiri AM, Mukhtar MH. Assessment of neutrophil gelatinase-associated lipocalin (ngal) and retinol-binding protein 4 (rbp4) in type 2 diabetic patients with nephropathy. Biomarker Insights 2016; 11: 31.
Gong Q, Xie Jn, Liu Y, Li Y, Su G. Differentially expressed micrornas in the development of early diabetic retinopathy. J Diabet Res 2017; 2017.
Ma J, Wang J, Liu Y, Wang C, Duan D, Lu N, et al. Comparisons of serum miRNA expression profiles in patients with diabetic retinopathy and type 2 diabetes mellitus. Clinics 2017; 72(2): 111-5.
Joglekar MV, Januszewski AS, Jenkins AJ, Hardikar AA. Circulating microRNA biomarkers of diabetic retinopathy. Diabetes 2016; 65(1): 22-4.
Mumtaz SN, Fahim MF, Arslan M, Shaikh SA, Kazi U, Memon MS. Prevalence of diabetic retinopathy in Pakistan; A systematic review. Pak J Med Sci 2018; 34(2): 493-500.
Ankit BS, Mathur G, Agrawal RP, Mathur KC. Stronger relationship of serum apolipoprotein A-1 and B with diabetic retinopathy than traditional lipids. Ind J Endocrinol Metabol 2017; 21(1): 102-5.
Zhang Q, Hu J, Hu Y, Ding Y, Zhu J, Zhuang C. Relationship between serum apolipoproteins levels and retinopathy risk in subjects with type 2 diabetes mellitus. Acta Diabetol 2018; 55(7): 681-9.
Ajith V, Gilsa E, Sudha V, Pushpalatha M, Geetha D, Andrews M. Serum lipids and apolipoproteins in diabetic retinopathy: A case control study. IOSR J Dent Med Sci 2015; 14(2): 70-3.
Hu A, Luo Y, Li T, Guo X, Ding X, Zhu X, et al. Low serum apolipoprotein A1/B ratio is associated with proliferative diabetic retinopathy in type 2 diabetes. Graefe's Arch Clin Exp Ophthalmol 2012; 250(7): 957-62.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 BioSight
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright in their published work and grant BioSight the right of first publication.
All articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license permits others to read, download, copy, distribute, print, search, link to, adapt, and build upon the work for any lawful purpose, including commercial use, provided that appropriate credit is given to the author(s) and BioSight, a link to the license is provided, and any changes are clearly indicated.
Authors may enter into separate, additional contractual arrangements for the non-exclusive distribution of the published version of their work, provided that its initial publication in BioSight is acknowledged.
Publication in BioSight does not require authors to transfer copyright to the journal or publisher.
